Given the heterogeneous nature of COPD, more study is needed to better classify disease phenotypes to allow directed therapeutics, and to further explore the etiology for the persistent decrement in CFTR function beyond the airway. This evidence concerns the gene CFTR and chronic obstructive pulmonary disease.